Data as of 3:56pm ET
| +1.45 / +1.05%|
The 19 analysts offering 12-month price forecasts for Amgen Inc have a median target of 145.00, with a high estimate of 165.00 and a low estimate of 121.00. The median estimate represents a +4.00% increase from the last price of 139.42.
The current consensus among 24 polled investment analysts is to Buy stock in Amgen Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.